Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 209

1.

Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.

Jong CB, Chen KY, Hsieh MY, Su FY, Wu CC, Voon WC, Hsieh IC, Shyu KG, Chong JT, Lin WS, Hsu CN, Ueng KC, Lai CL.

Int J Cardiol. 2019 Mar 14. pii: S0167-5273(18)37278-4. doi: 10.1016/j.ijcard.2019.03.021. [Epub ahead of print]

PMID:
30905518
2.

Catalpol Ameliorates Neointimal Hyperplasia in Diabetic Rats.

Lin CM, Wang BW, Fang WJ, Pan CM, Shyu KG, Hou SW.

Planta Med. 2019 Mar;85(5):406-411. doi: 10.1055/a-0818-3689. Epub 2019 Jan 4.

PMID:
30609436
3.

Corrigendum.

Shyu KG.

Eur J Clin Invest. 2019 Jan;49(1):e13046. doi: 10.1111/eci.13046. No abstract available.

PMID:
30585321
4.

Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.

Cheng WP, Lo HM, Wang BW, Chua SK, Shyu KG.

J Cell Mol Med. 2019 Feb;23(2):1406-1414. doi: 10.1111/jcmm.14044. Epub 2018 Dec 3.

5.

Hyperbaric oxygen boosts long noncoding RNA MALAT1 exosome secretion to suppress microRNA-92a expression in therapeutic angiogenesis.

Shyu KG, Wang BW, Pan CM, Fang WJ, Lin CM.

Int J Cardiol. 2019 Jan 1;274:271-278. doi: 10.1016/j.ijcard.2018.09.118. Epub 2018 Oct 2.

PMID:
30301563
6.

In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

Chen KC, Yin WH, Wu CC, Chan SH, Wu YW, Yang Wang K, Chang KC, Hwang JJ, Voon WC, Hsieh IC, Chong JT, Lin WS, Hsu CN, Ueng KC, Hsia CP, Liu JC, Yeh JS, Mar GY, Shih JY, Kuo JY, Tsao HM, Tseng WK, Yang CH, Chang CC, Chiang CE, Lei MH, Lin JF, Shyu KG.

Acta Cardiol Sin. 2018 May;34(3):211-223. doi: 10.6515/ACS.201805_34(3).20180207B.

7.

2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.

Li YH, Fang CY, Hsieh IC, Huang WC, Lin TH, Sung SH, Chiu CZ, Wu CJ, Shyu KG, Chang PY, Fang CC, Lu TM, Chen CP, Tai WC, Sheu CC, Wei KC, Huang YH, Wu HM, Hwang JH.

Acta Cardiol Sin. 2018 May;34(3):201-210. doi: 10.6515/ACS.201805_34(3).20180302A. Review.

8.

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.

Chiang CE, Lin SY, Lin TH, Wang TD, Yeh HI, Chen JF, Tsai CT, Hung YJ, Li YH, Liu PY, Chang KC, Wang KL, Chao TH, Shyu KG, Yang WS, Ueng KC, Chu PH, Yin WH, Wu YW, Cheng HM, Shin SJ, Huang CN, Chuang LM, Lin SJ, Yeh SJ, Sheu WH, Lin JL.

J Chin Med Assoc. 2018 Mar;81(3):189-222. doi: 10.1016/j.jcma.2018.01.001. Epub 2018 Feb 13.

9.

Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.

Shyu KG, Velusamy M, Hsia CW, Yang CH, Hsia CH, Chou DS, Jayakumar T, Sheu JR, Li JY.

Int J Mol Med. 2018 May;41(5):2589-2600. doi: 10.3892/ijmm.2018.3472. Epub 2018 Feb 7.

10.

MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.

Wang BW, Fang WJ, Shyu KG.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12867. Epub 2017 Dec 8. Erratum in: Eur J Clin Invest. 2019 Jan;49(1):e13046.

PMID:
29178342
11.

Effects of flavonoids on MicroRNA 145 regulation through Klf4 and myocardin in neointimal formation in vitro and in vivo.

Lin CM, Wang BW, Pan CM, Fang WJ, Chua SK, Hou SW, Chang H, Shyu KG.

J Nutr Biochem. 2018 Feb;52:27-35. doi: 10.1016/j.jnutbio.2017.08.016. Epub 2017 Sep 14.

PMID:
29127880
12.

Mortality prediction using CHADS2/CHA2DS2-VASc/R2CHADS2 scores in systolic heart failure patients with or without atrial fibrillation.

Chen YL, Cheng CL, Huang JL, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Wang CC, Yin WH, Lin JL, Chen SM; TSOC-HFrEF Registry investigators and committee.

Medicine (Baltimore). 2017 Oct;96(43):e8338. doi: 10.1097/MD.0000000000008338.

13.

The Role of Endoglin in Myocardial Fibrosis.

Shyu KG.

Acta Cardiol Sin. 2017 Sep;33(5):461-467. Review.

14.

[Factors Associated With Successful Smoking Cessation in Male Patients With Coronary Artery Disease at 3 Months After Hospital Discharge].

Wang HL, Wang PC, Wu YW, Shyu KG.

Hu Li Za Zhi. 2017 Aug;64(4):34-43. doi: 10.6224/JN.000052. Chinese.

PMID:
28762223
15.

The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.

Chiang CE, Wang TD, Lin TH, Yeh HI, Liu PY, Cheng HM, Chao TH, Chen CH, Shyu KG, Ueng KC, Chen CY, Chu PH, Sung SH, Wang KL, Li YH, Wang KY, Chiang FT, Lai WT, Chen JH, Chen WJ, Yeh SJ, Chen MF, Lin SJ, Lin JL.

Acta Cardiol Sin. 2017 May;33(3):213-225. Review.

16.

One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry.

Chang HY, Wang CC, Wu YW, Chu PH, Wu CC, Hsu CH, Wen MS, Voon WC, Lin WS, Huang JL, Chen SM, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Lin JL, Mar GY, Chan KC, Kuo JY, Wang JH, Chen ZC, Tseng WK, Cherng WJ, Yin WH.

Acta Cardiol Sin. 2017 Mar;33(2):127-138.

17.

Can osteoporosis increase the incidence of heart failure in adults?

Chiu CZ, Yeh JH, Shyu KG, Hou SM, Lin CL, Liang JA.

Curr Med Res Opin. 2017 Jun;33(6):1119-1125. doi: 10.1080/03007995.2017.1308343. Epub 2017 Apr 13.

PMID:
28301957
18.

Tumor Necrosis Factor-Alpha and the ERK Pathway Drive Chemerin Expression in Response to Hypoxia in Cultured Human Coronary Artery Endothelial Cells.

Chua SK, Shyu KG, Lin YF, Lo HM, Wang BW, Chang H, Lien LM.

PLoS One. 2016 Oct 28;11(10):e0165613. doi: 10.1371/journal.pone.0165613. eCollection 2016.

19.

Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.

Lin CM, Chang H, Wang BW, Shyu KG.

J Cell Mol Med. 2016 Nov;20(11):2045-2055. doi: 10.1111/jcmm.12895. Epub 2016 Jun 16.

20.

Atorvastatin alleviates cardiomyocyte apoptosis by suppressing TRB3 induced by acute myocardial infarction and hypoxia.

Cheng WP, Lo HM, Wang BW, Chua SK, Lu MJ, Shyu KG.

J Formos Med Assoc. 2017 May;116(5):388-397. doi: 10.1016/j.jfma.2016.07.010. Epub 2016 Sep 17.

Supplemental Content

Loading ...
Support Center